Hail And Hearty Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
- Paid Up Capital ₹ 7.00 M
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 3.70 M
About Hail And Hearty Pharmaceuticals
Hail And Hearty Pharmaceuticals Private Limited (HAHPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 April 2005 and has a history of 19 years and nine months. Its registered office is in Jaipur, Rajasthan.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹3.70 M.
Mahendra Khurana and Vineet Goyal serve as directors at the Company.
Company Details
-
LocationJaipur, Rajasthan
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2005PTC020596
-
Company No.
020596
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Apr 2005
-
Date of AGM
30 Sep 2010
-
Date of Balance Sheet
31 Mar 2010
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Hail And Hearty Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Khurana
|
Director | 30-Mar-2010 | Current |
|
Vineet Goyal
|
Director | 19-Apr-2005 | Current |
Financial Performance of Hail And Hearty Pharmaceuticals.
Enhance accessibility to Hail And Hearty Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hail And Hearty Pharmaceuticals?
Unlock access to Hail And Hearty Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Adon Pharmaceuticals Private LimitedMahendra Khurana and Vineet Goyal are mutual person
Charges (Loans)
₹3.70 M
₹0
Charges Breakdown by Lending Institutions
- Small Industries Development Bank Of India : 0.37 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2006 | Small Industries Development Bank Of India | ₹3.70 M | Open |
How Many Employees Work at Hail And Hearty Pharmaceuticals?
Unlock and access historical data on people associated with Hail And Hearty Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hail And Hearty Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hail And Hearty Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
